Profile for European Patent Office Patent: 1405852
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Denmark | CA 2015 00052 | ⤷ Start Trial |
| Luxembourg | 92835 | ⤷ Start Trial |
| France | 15C0068 | ⤷ Start Trial |
| Netherlands | 300760 | ⤷ Start Trial |
| Denmark | CR 2015 00052 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1405852
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 7,365,205 | Apr 18, 2027 | Daiichi Sankyo Inc | SAVAYSA | edoxaban tosylate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
